Trials / Completed
CompletedNCT00406042
The Role of Steroids Following Selective Laser Trabeculoplasty
The Role of Topical Prednisolone Acetate Following Selective Laser Trabeculoplasty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (planned)
- Sponsor
- West Virginia University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate whether or not using topical steroids after selective laser trabeculoplasty affects intraocular pressure outcomes.
Detailed description
Subjects undergoing bilateral SLT will be randomly assigned to use prednisolone acetate 1% in one eye four times daily with no treatment in the fellow eye, for one week following SLT. Examinations will occur at baseline, and one week, one month and three months after SLT. IOP and anterior chamber inflammation will be noted at each visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prednisolone acetate 1% |
Timeline
- Start date
- 2005-09-01
- Completion
- 2006-06-01
- First posted
- 2006-12-04
- Last updated
- 2007-03-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00406042. Inclusion in this directory is not an endorsement.